Paper review 2015.01.07 MIYEON SHIN. 2 Intro- 1.PBDEs have been banned in several countries. 2.There are sig. corr b/w intake of food and body burdens.

Slides:



Advertisements
Similar presentations
Module II The Basics of the Brain, the Body and Drug Actions
Advertisements

HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Pharmacokinetics Ampicillin Ceftriaxone Vancomycin Half-Life: hr
Why does the body need protein? n Dietary protein provides needed amino acids n Used to make new protein in the body n Protein is made in the body for:
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
Distribution & Fate Lesson 5. Distribution n Drug disperses throughout system l does not reach target l silent receptors n Distributes in l Blood & extracellular.
Creative DedicatedExperts PCBs: Real World Considerations Exposure and Toxicity Diane M. Silverman, PhD.
EOH:2504 Principles of Environmental Exposure Instructor: Dr. Volz Yi-Han Huang EOH MPH student Dec
1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College March.
R E S E A R C H T R I A N G L E P A R K, N O R T H C A R O L I N A.
Vitamins Organic compounds necessary for normal physiologic function. Most cannot be synthesized in the body and must be present in the diet.
One-compartment open model: Intravenous bolus administration
Digestible compounds: protein amino acids
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
“The Dose makes the Poison”
Biotransformation and metabolism
You have learned a LOT so far. A few extra facts to throw in No single reproducible abnormality in any NT, enzyme, receptor or gene has been found to.
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
Bioavailability Dr Mohammad Issa.
3. Method of inspection Requirements for the Method of Inspection We assume that k a is much larger than k el. That is, k a is at least five times greater.
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
PHARMACOKINETIC MODELS
PHARMACOKINETICS Part 3.
Interconversion of Hydroxylated and Methoxylated Polybrominated Diphenyl Ethers in Japanese Medaka Yi Wan 1, Steve Wiseman 1, Fengyan Liu 1, Xiaowei Zhang.
Prof. Dr. Magdy M. Saad Food Safety Dept., NRC, Egypt.
1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College January.
EHS 507 Food Exposures: Fruits and Vegetables  Fruits and vegetables may become contaminated by multiple pathways –Purposeful spraying or soil treatment.
TDM Therapeutic Drug Monitoring
Criteria for Inherently toxic (iT) in CEPA, UNEP Proposed iT criteria for non-human organisms –aquatic acute effects levels of < 1 mg/L –above 1 mg/L.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Drug Transfer into Milk: Clinical Methods & Issues Patrick J. McNamara University of Kentucky College of Pharmacy College of Pharmacy.
Pharmacology I BMS 242 Lecture 4 Pharmacokienetic Principles (3&4): Drug Metabolism and Excretion [Elimination] Dr. Aya M. Serry 2016.
415 PHT Plasma Level – Time Curve
Foundation Knowledge and Skills
Energy balance – ch. 10. Energy The ability to do work Quantitatively the most important nutrient in the diet Derived from the oxidation of organic molecules.
이 장 우. 1. Introduction  Bisphenol A is a high production volume chemical -Annual production of over six billion pounds -polycarbonate plastics.
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
METABOLISM OF VITAMIN K
Compartmental Models and Volume of Distribution
Physiology for Engineers
Life Span Consideration
Outdoor Water Sediment Study – Adding Effects of Sunlight to Aquatic System Exposure Assessment Cecilia Mucha Hirata (DuPont Crop Protection, Newark DE,
A fecal P test for assessing P overfeeding on dairy farms
Waleed Faisal, Caitriona O'Driscoll, Brendan Griffin1
HYGIENE STANDARDS AND OCCUPATIONAL EXPOSURE LIMITS
Zebrafish feed model: Applications in aquaculture nutrition research
Discussion & Conclusion
Drug Metabolism Drugs are most often eliminated by biotransformation and/or excretion into the urine or bile. The process of metabolism transforms lipophilic.
  URIC ACID Muthana A. Al-Shemeri.
General Toxicology General Considerations in Toxicology Lec
Pharmacokinetics & pharmacodynamcs
Absorption, transport and metabolism of riboflavin
Pharmacokinetics and Factors of Individual Variation
Conceptual Subdivisions of Pharmacology
Conceptual Subdivisions of Pharmacology
이 장 우
이 장 우.
Volume 6, Issue 3, Pages (September 2007)
Volume 141, Issue 3, Pages e4 (September 2011)
1 Concentration-time curve
Basic Biopharmaceutics
Clinical Pharmacokinetics
Introduction to Experimental Design
Volume 6, Issue 3, Pages (September 2007)
BIOAVAILABILITY.
Medication Administration for Pediatrics
Paper review Miyeon Shin 21 Apr 2015.
Forensic Toxicology Alcohol.
Presentation transcript:

Paper review MIYEON SHIN

2

Intro- 1.PBDEs have been banned in several countries. 2.There are sig. corr b/w intake of food and body burdens (USA, North EU etc). 3.No association between two var. in Swedish women. 4.Blood conc. >> 3 ?

Intro- 5. Indoor dust??? (UK, Singapore, Canada) 6. More susceptible in Child than adult 7. Other uncertainties (Estimating exposure from dust); Bioavailability 8. Usually Bioav.of PBDEs is assumed to be 100%. 4

Intro Subchronic low-level exposures (21 days) ADME Compare b/w groups Retained PBDEs Excreted PBDEs Retained PBDEs Bioav. by congener

Materials and Methods 6 Sac. Time Dust Low (4 rats) 24 h after last feeding High (4 rats) Corn Oil Low (4 rats) High (13 rats) 3 rats (3 day), 3 rats (7 day), 3 rats (14 day), 4 rats (24 h after last feeding) Total 29 rats To investigate steady state time point

Daily intake amount 7

Collected samples Epididymal fat Liver (for both bioav. And mRNA assay) Kidney Brain GI tract Remaining carcass Feces (daily) & Fecal pellets in GI tract Urine (4 day intervals) 8 Materials and Methods

Analysis (1) Tissues, feces and urine were homogenized and spiked with ten 13 C-labeled recovery standards and extracted. Rat chow, NIST dust, corn oil were extracted. DE-71, DE79 and DE83R was also analyzed. High resolution GC/MS Column: DB5-MS (30m) 9 Materials and Methods

Analysis (2) Hydroxylated metabolites from the feces were analyzed by a GC/MS method as MeO-PBDEs (tetra- to hexa BDEs). To investigate gene expression of Cyp2b1 and Cyp2b, RT-PCR was performed (ABI Prism 7700). 10 Materials and Methods

Calculation (3) Bioconcentration factors (BCFs) - ratio b/w conc. in tissues and in diet. Statistical- -ANOVA (var 1:vehicle, var 2: dose, dependent var: PBDE level) -1way ANOVA for Steady state (compare among sac. days). 11 Materials and Methods

Results and Discussion Dose level (low and high) were studied to determine uptake degree. Determine enzyme modulation at relatively low levels (7-9 p.p.b, slightly above the ave.conc. in other countries for salmon and breast milk) 12

Dosed amount/Steady state The rat chow had measurable amounts of several PBDEs leading to body burdens in the control rat tissues. ->subtracted from the dosed rat levels To explore the steady state, epididymal fat was analyzed (3, 7, 14 and 21 days). 13 Results and Discussion

BCFs 14 Results and Discussion 1) Epididymal fat 2) Liver Tri- to hexa BDE Hepta- to Deca BDE

Conclusion (1) No differences in BCFs were consistently observed for either the high- or low-dose levels or the dust or corn oil dose vehicles; - the majority of PBDEs concentrate to similar degree in rat tissues after injestion of either dust or oil over the given dose range. 15 Results and Discussion

Cytochrome P450 (Cyp) 16 Results and Discussion

17 Results and Discussion

Debromination There is a sig. degradation mechanism for BDE99, 183, 209 in fish species. But minor mechanism in rats. -> Because they used PBDE mixture in their study, it Is impossible to investigate about PBDE debromination. 18 Results and Discussion

Absorption Absorption was investigated in a manner that accounts for these metabolic transformations. Fecal excretion was the major route of elimination 19 Results and Discussion

20 Results and Discussion

Metabolism difference Feces were analyzed for monohydroxylated BDEs. 4’-MeO-BDE49 (0.3 % of the total tetra- to hexa-BDE dose), 4’MeO-BDE-101 (0.5 % of the total tetra- to hexa-BDE dose), a methoxy-hexaBDE (0.1 %) No difference in the % between two high dose groups (p>0.05) 21 Results and Discussion

Other The mechanism of formation and the characterization of these bound residues are unknown. The involvement of enzyme systems other than those investigated in this study or gut microbial metabolism of PBDEs may also be of significance (CYP isozymes, mercapturic acid pathway enzimes, or deiodinases etc.). 22 Results and Discussion

Grand conclusion PBDEs in dust bioconcentrate into rat tissues to the same or greater degree as PBDE administered in an oil matrix. -> Household dust is a likely source of PBDE intake and must be taken into account when human exposure assessment. 23 Results and Discussion

Thank you for listening! 24